Symbols / SNGX Stock $0.39 +3.25% Soligenix, Inc.
SNGX (Stock) Chart
Stock Fundamentals
|
|
|
|
|
|
About
No company description available for this symbol.
Ratings
Current target
—
Low
—
High
—
Mean
—
- Skin lymphoma drug study stops early after futility review - Stock Titan ue, 28 Apr 2026 07
- Soligenix (SNGX) price target decreased by 60.00% to 6.12 - MSN ue, 19 May 2026 02
- SNGX News | SOLIGENIX INC (NASDAQ:SNGX) - ChartMill Mon, 11 May 2026 07
- Soligenix Announces Pricing of $7.5 Million Public Offering - PR Newswire Fri, 26 Sep 2025 07
- Companies Like Soligenix (NASDAQ:SNGX) Could Be Quite Risky - Yahoo Finance Wed, 20 Aug 2025 07
- $SNGX stock is down 20% today. Here's what we see in our data. - Quiver Quantitative Wed, 17 Dec 2025 08
- Soligenix (SNGX) Faces Setback in FLASH2 Study Results - GuruFocus Fri, 08 May 2026 15
- Soligenix stock tumbles after pricing $7.5 million public offering - Investing.com Fri, 26 Sep 2025 07
- SNGX stock slumps to record low after lymphoma trial fails – all eyes now on Behçet’s disease treatment - MSN ue, 28 Apr 2026 19
- Soligenix says pivotal HyBryte trial readouts arrive in 2026 - Stock Titan ue, 31 Mar 2026 07
- These stocks have an unusual volume in today's session - ChartMill ue, 05 May 2026 07
- LCID, SNGX, SRAD stock hit 52-week lows today: What's driving the selloff? - MSN Sun, 03 May 2026 01
- UK flags Soligenix therapy as 'promising' for rare Behçet's disease patients - Stock Titan ue, 10 Mar 2026 07
- Skin lymphoma study finds HyBryte beat Valchlor with no related side effects - Stock Titan hu, 02 Apr 2026 07
- Soligenix (SNGX) registers 1,054,688 resale shares; Q1 cash $6.03M - Stock Titan Fri, 08 May 2026 07
Financials
Statement View
| Line Item | Trend | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|---|
| Total Revenue |
|
0.00
|
0.00
|
0.00
-100.00%
|
0.25
|
| Operating Revenue |
|
0.00
|
0.00
|
0.00
-100.00%
|
0.25
|
| Cost Of Revenue |
|
0.00
-100.00%
|
0.12
-83.91%
|
0.74
+34.72%
|
0.55
|
| Reconciled Cost Of Revenue |
|
0.00
-100.00%
|
0.12
-83.91%
|
0.74
+34.72%
|
0.55
|
| Gross Profit |
|
0.00
+100.00%
|
-0.12
+83.91%
|
-0.74
-146.67%
|
-0.30
|
| Operating Expense |
|
11.85
+26.75%
|
9.35
+34.82%
|
6.93
-49.79%
|
13.81
|
| Research And Development |
|
7.49
+43.31%
|
5.22
+57.68%
|
3.31
-58.30%
|
7.94
|
| Selling General And Administration |
|
4.36
+3.41%
|
4.22
-5.95%
|
4.48
-33.03%
|
6.69
|
| General And Administrative Expense |
|
4.36
+3.41%
|
4.22
-5.95%
|
4.48
-33.03%
|
6.69
|
| Other Gand A |
|
4.36
+3.41%
|
4.22
-5.95%
|
4.48
-33.03%
|
6.69
|
| Other Operating Expenses |
|
—
|
-0.09
+89.12%
|
-0.86
-3.77%
|
-0.83
|
| Total Expenses |
|
11.85
+25.15%
|
9.46
+23.34%
|
7.67
-46.54%
|
14.36
|
| Operating Income |
|
-11.85
-25.15%
|
-9.46
-23.34%
|
-7.67
+45.60%
|
-14.11
|
| Total Operating Income As Reported |
|
-11.85
-25.49%
|
-9.44
-22.62%
|
-7.70
+45.94%
|
-14.24
|
| EBITDA |
|
-11.84
-25.19%
|
-9.46
-23.37%
|
-7.67
+45.64%
|
-14.11
|
| Normalized EBITDA |
|
-11.83
-17.90%
|
-10.03
-34.89%
|
-7.44
+47.15%
|
-14.08
|
| Reconciled Depreciation |
|
0.00
-44.55%
|
0.01
-11.29%
|
0.01
-73.32%
|
0.02
|
| EBIT |
|
-11.85
-25.15%
|
-9.46
-23.34%
|
-7.67
+45.69%
|
-14.13
|
| Total Unusual Items |
|
-0.01
-102.05%
|
0.58
+351.79%
|
-0.23
-647.88%
|
-0.03
|
| Total Unusual Items Excluding Goodwill |
|
-0.01
-102.05%
|
0.58
+351.79%
|
-0.23
-647.88%
|
-0.03
|
| Special Income Charges |
|
0.00
-100.00%
|
0.31
+214.55%
|
-0.27
|
0.00
|
| Other Special Charges |
|
—
|
-0.31
-214.55%
|
0.27
|
—
|
| Net Income |
|
-11.08
-34.04%
|
-8.27
-34.62%
|
-6.14
+55.50%
|
-13.80
|
| Pretax Income |
|
-11.59
-33.56%
|
-8.68
-9.70%
|
-7.91
+47.11%
|
-14.95
|
| Net Non Operating Interest Income Expense |
|
0.27
+26.26%
|
0.21
+535.54%
|
-0.05
+94.03%
|
-0.82
|
| Interest Expense Non Operating |
|
—
|
-0.21
-535.54%
|
0.05
-94.03%
|
0.82
|
| Net Interest Income |
|
0.27
+26.26%
|
0.21
+535.54%
|
-0.05
+94.03%
|
-0.82
|
| Interest Expense |
|
—
|
-0.21
-535.54%
|
0.05
-94.03%
|
0.82
|
| Other Income Expense |
|
-0.01
-102.03%
|
0.58
+410.57%
|
-0.19
-652.18%
|
-0.02
|
| Other Non Operating Income Expenses |
|
0.00
+190.70%
|
0.00
-99.90%
|
0.04
+629.99%
|
0.01
|
| Gain On Sale Of Security |
|
-0.01
-104.50%
|
0.26
+489.29%
|
0.04
+245.83%
|
-0.03
|
| Tax Provision |
|
-0.51
-23.83%
|
-0.41
+76.86%
|
-1.77
-53.07%
|
-1.15
|
| Tax Rate For Calcs |
|
0.00
-6.38%
|
0.00
-79.02%
|
0.00
+190.91%
|
0.00
|
| Tax Effect Of Unusual Items |
|
-0.00
-101.92%
|
0.03
+152.83%
|
-0.05
-2075.66%
|
-0.00
|
| Net Income Including Noncontrolling Interests |
|
-11.08
-34.04%
|
-8.27
-34.62%
|
-6.14
+55.50%
|
-13.80
|
| Net Income From Continuing Operation Net Minority Interest |
|
-11.08
-34.04%
|
-8.27
-34.62%
|
-6.14
+55.50%
|
-13.80
|
| Net Income From Continuing And Discontinued Operation |
|
-11.08
-34.04%
|
-8.27
-34.62%
|
-6.14
+55.50%
|
-13.80
|
| Net Income Continuous Operations |
|
-11.08
-34.04%
|
-8.27
-34.62%
|
-6.14
+55.50%
|
-13.80
|
| Normalized Income |
|
-11.07
-25.57%
|
-8.81
-47.81%
|
-5.96
+56.69%
|
-13.77
|
| Net Income Common Stockholders |
|
-11.08
-34.04%
|
-8.27
-34.62%
|
-6.14
+55.50%
|
-13.80
|
| Diluted EPS |
|
-2.14
+57.03%
|
-4.98
+60.66%
|
-12.66
+83.55%
|
-76.96
|
| Basic EPS |
|
-2.14
+57.03%
|
-4.98
+60.66%
|
-12.66
+83.55%
|
-76.96
|
| Basic Average Shares |
|
5.19
+212.50%
|
1.66
+242.36%
|
0.48
+170.25%
|
0.18
|
| Diluted Average Shares |
|
5.19
+212.50%
|
1.66
+242.36%
|
0.48
+170.25%
|
0.18
|
| Diluted NI Availto Com Stockholders |
|
-11.08
-34.04%
|
-8.27
-34.62%
|
-6.14
+55.50%
|
-13.80
|
| Total Other Finance Cost |
|
-0.27
-26.26%
|
-0.21
-535.54%
|
0.05
|
—
|
| Line Item | Trend | 2023-12-31 |
|---|---|---|
| Total Assets |
|
9.80
|
| Current Assets |
|
9.51
|
| Cash Cash Equivalents And Short Term Investments |
|
8.45
|
| Cash And Cash Equivalents |
|
8.45
|
| Receivables |
|
0.20
|
| Accounts Receivable |
|
0.00
|
| Other Receivables |
|
0.20
|
| Prepaid Assets |
|
—
|
| Current Deferred Assets |
|
0.00
|
| Other Current Assets |
|
0.87
|
| Total Non Current Assets |
|
0.29
|
| Net PPE |
|
0.24
|
| Gross PPE |
|
0.24
|
| Accumulated Depreciation |
|
-0.12
|
| Properties |
|
0.00
|
| Buildings And Improvements |
|
0.23
|
| Machinery Furniture Equipment |
|
0.01
|
| Other Properties |
|
—
|
| Non Current Accounts Receivable |
|
0.03
|
| Non Current Deferred Assets |
|
0.00
|
| Non Current Prepaid Assets |
|
0.02
|
| Other Non Current Assets |
|
—
|
| Total Liabilities Net Minority Interest |
|
7.27
|
| Current Liabilities |
|
6.15
|
| Payables And Accrued Expenses |
|
3.53
|
| Payables |
|
1.11
|
| Accounts Payable |
|
1.11
|
| Current Accrued Expenses |
|
2.42
|
| Pensionand Other Post Retirement Benefit Plans Current |
|
0.25
|
| Current Debt And Capital Lease Obligation |
|
2.37
|
| Current Debt |
|
2.25
|
| Other Current Borrowings |
|
2.25
|
| Current Capital Lease Obligation |
|
0.12
|
| Total Non Current Liabilities Net Minority Interest |
|
1.12
|
| Long Term Debt And Capital Lease Obligation |
|
1.12
|
| Long Term Debt |
|
1.01
|
| Long Term Capital Lease Obligation |
|
0.11
|
| Preferred Securities Outside Stock Equity |
|
0.00
|
| Stockholders Equity |
|
2.52
|
| Common Stock Equity |
|
2.52
|
| Capital Stock |
|
0.00
|
| Common Stock |
|
0.00
|
| Preferred Stock |
|
0.00
|
| Share Issued |
|
0.65
|
| Ordinary Shares Number |
|
0.65
|
| Treasury Shares Number |
|
0.00
|
| Additional Paid In Capital |
|
228.20
|
| Retained Earnings |
|
-225.70
|
| Gains Losses Not Affecting Retained Earnings |
|
0.02
|
| Other Equity Adjustments |
|
0.02
|
| Total Equity Gross Minority Interest |
|
2.52
|
| Total Capitalization |
|
3.53
|
| Working Capital |
|
3.36
|
| Invested Capital |
|
5.78
|
| Total Debt |
|
3.49
|
| Capital Lease Obligations |
|
0.23
|
| Net Tangible Assets |
|
2.52
|
| Tangible Book Value |
|
2.52
|
| Line Item | Trend | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|---|
| Operating Cash Flow |
|
-10.27
-22.17%
|
-8.40
+2.33%
|
-8.60
+31.98%
|
-12.65
|
| Cash Flow From Continuing Operating Activities |
|
-10.27
-22.17%
|
-8.40
+2.33%
|
-8.60
+31.98%
|
-12.65
|
| Net Income From Continuing Operations |
|
-11.08
-34.04%
|
-8.27
-34.62%
|
-6.14
+55.50%
|
-13.80
|
| Depreciation Amortization Depletion |
|
0.00
-44.55%
|
0.01
-11.29%
|
0.01
-73.32%
|
0.02
|
| Depreciation And Amortization |
|
0.00
-44.55%
|
0.01
-11.29%
|
0.01
-73.32%
|
0.02
|
| Other Non Cash Items |
|
0.19
+39.90%
|
0.14
-44.59%
|
0.25
-32.65%
|
0.37
|
| Stock Based Compensation |
|
0.59
+78.16%
|
0.33
-10.90%
|
0.37
+11.04%
|
0.33
|
| Operating Gains Losses |
|
—
|
—
|
0.39
|
—
|
| Gain Loss On Investment Securities |
|
—
|
—
|
-0.04
|
—
|
| Unrealized Gain Loss On Investment Securities |
|
0.00
+100.00%
|
-0.26
-505.89%
|
-0.04
|
—
|
| Change In Working Capital |
|
0.03
+109.13%
|
-0.35
+89.86%
|
-3.44
-908.61%
|
0.43
|
| Change In Receivables |
|
0.00
-100.00%
|
0.22
+548.82%
|
0.03
-65.11%
|
0.10
|
| Changes In Account Receivables |
|
—
|
—
|
—
|
0.02
|
| Change In Prepaid Assets |
|
0.01
+127.91%
|
-0.04
+93.37%
|
-0.59
-6907.05%
|
0.01
|
| Change In Payables And Accrued Expense |
|
0.14
+133.19%
|
-0.41
+85.30%
|
-2.77
-743.73%
|
0.43
|
| Change In Accrued Expense |
|
0.15
+77.77%
|
0.09
+199.71%
|
-0.09
-353.52%
|
0.03
|
| Change In Payable |
|
-0.02
+96.65%
|
-0.49
+81.65%
|
-2.69
-776.94%
|
0.40
|
| Change In Account Payable |
|
-0.02
+96.65%
|
-0.49
+81.65%
|
-2.69
-776.94%
|
0.40
|
| Change In Other Working Capital |
|
—
|
—
|
—
|
0.03
|
| Change In Other Current Liabilities |
|
-0.11
+6.11%
|
-0.12
-11.76%
|
-0.11
+1.96%
|
-0.11
|
| Investing Cash Flow |
|
-0.01
|
0.00
|
0.00
+100.00%
|
-0.01
|
| Cash Flow From Continuing Investing Activities |
|
-0.01
|
0.00
|
0.00
+100.00%
|
-0.01
|
| Net PPE Purchase And Sale |
|
-0.01
|
0.00
|
0.00
+100.00%
|
-0.01
|
| Purchase Of PPE |
|
-0.01
|
0.00
|
0.00
+100.00%
|
-0.01
|
| Capital Expenditure |
|
-0.01
|
—
|
—
|
-0.01
|
| Financing Cash Flow |
|
10.39
+33.84%
|
7.76
+111.88%
|
3.66
+4668.89%
|
0.08
|
| Cash Flow From Continuing Financing Activities |
|
10.39
+33.84%
|
7.76
+111.88%
|
3.66
+4668.89%
|
0.08
|
| Net Issuance Payments Of Debt |
|
-1.37
0.00%
|
-1.37
+80.39%
|
-7.00
|
0.00
|
| Issuance Of Debt |
|
—
|
—
|
—
|
—
|
| Repayment Of Debt |
|
-1.37
0.00%
|
-1.37
+80.39%
|
-7.00
|
0.00
|
| Long Term Debt Issuance |
|
—
|
—
|
—
|
—
|
| Long Term Debt Payments |
|
-1.37
0.00%
|
-1.37
+80.39%
|
-7.00
|
0.00
|
| Net Long Term Debt Issuance |
|
-1.37
0.00%
|
-1.37
+80.39%
|
-7.00
|
0.00
|
| Net Common Stock Issuance |
|
12.16
+109.27%
|
5.81
-49.83%
|
11.59
+14502.01%
|
0.08
|
| Proceeds From Stock Option Exercised |
|
0.31
-93.14%
|
4.45
+134794.57%
|
0.00
|
0.00
|
| Net Other Financing Charges |
|
-0.71
+37.22%
|
-1.13
-21.69%
|
-0.93
-36499.76%
|
-0.00
|
| Changes In Cash |
|
0.12
+118.18%
|
-0.64
+87.02%
|
-4.94
+60.74%
|
-12.59
|
| Effect Of Exchange Rate Changes |
|
0.00
-100.00%
|
0.01
-45.17%
|
0.03
+127.42%
|
-0.10
|
| Beginning Cash Position |
|
7.82
-7.42%
|
8.45
-36.78%
|
13.36
-48.70%
|
26.04
|
| End Cash Position |
|
7.94
+1.49%
|
7.82
-7.42%
|
8.45
-36.78%
|
13.36
|
| Free Cash Flow |
|
-10.27
-22.24%
|
-8.40
+2.33%
|
-8.60
+32.05%
|
-12.66
|
| Interest Paid Supplemental Data |
|
0.04
-84.61%
|
0.23
-58.75%
|
0.55
-35.61%
|
0.86
|
| Income Tax Paid Supplemental Data |
|
0.12
+189.73%
|
0.04
+103.39%
|
0.02
+29.22%
|
0.02
|
| Common Stock Issuance |
|
12.16
+109.27%
|
5.81
-49.83%
|
11.59
+14502.01%
|
0.08
|
| Issuance Of Capital Stock |
|
12.16
+109.27%
|
5.81
-49.83%
|
11.59
+14502.01%
|
0.08
|
SEC Filings
Recent 10-K, 10-Q, 8-K, and Form 4 (insider) filings.
- 10-Q2026-05-08 View
- 8-K2026-04-28 View
- 10-K2026-03-31 View
- 8-K2026-02-12 View
- 8-K2026-01-23 View
- 42025-12-12 View
- 42025-12-12 View
- 42025-12-12 View
- 42025-12-12 View
- 8-K2025-11-18 View
- 10-Q2025-11-07 View
- 42025-10-03 View
- 8-K2025-09-29 View
- 8-K2025-08-18 View
- 8-K2025-08-15 View
- 10-Q2025-08-14 View
- 8-K2025-07-31 View
- 42025-06-20 View
- 42025-06-20 View
- 42025-06-20 View
Trades
| Date | User | Broker | Pattern | Type | Position Size | Entry Price | Trade P&L | Status |
|---|
Posts
| Published | Title | Author | Category |
|---|